Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Licensing deals
Biotech
Sanofi scoops up China rights to Cytokinetics’ heart disease med
The rights will be transferred from Corxel, which had offered Cytokinetics up to $200 million in biobucks for regional rights in 2020.
Gabrielle Masson
Dec 20, 2024 11:07am
Oncology biotech licenses Genevant tech for up to $123M
Dec 20, 2024 6:00am
Idorsia's Tryvio sale behind schedule, but layoffs on track
Dec 20, 2024 4:42am
VC firm pens $608M deal to direct NGM MASH drug to rare disease
Dec 19, 2024 10:30am
Astellas pays Sangamo $20M to boost neurological gene therapies
Dec 19, 2024 7:13am
Merck pays $112M upfront for Hansoh's preclinical GLP-1
Dec 18, 2024 7:44am
